Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Gabrielson

Showing results (81-90 of 134) with videos related to

Pageof 14
Sort By:
Molecular Cancer Therapeutics|August 28, 2020
Concurrent Targeting of Potential Cancer Stem Cells Regulating Pathways Sensitizes Lung Adenocarcinoma to Standard ChemotherapyMasahiro Shibata, Akira Ooki, Yoshikuni Inokawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2004
Hypermethylation of the GATA genes in lung cancerMingzhou Guo, Yoshimitsu Akiyama, Michael G House, et al.
The Oncologist|March 1, 2018
A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy-Naïve Advanced or Metastatic Nonsquamous Non-Small Cell Lung CancerKristen A Marrone, Xian Zhou, Patrick M Forde, et al.
Plos Medicine|October 6, 2006
Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancerAnju Singh, Vikas Misra, Rajesh K Thimmulappa, et al.
Cancer Research|June 18, 2003
Dykellic acid inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting nuclear factor kappa B transcriptional activityJu-Hyung Woo, Jong-Wook Park, Sung-Hee Lee, et al.
Scientific Reports|September 3, 2015
Phosphoproteomic profiling of tumor tissues identifies HSP27 Ser82 phosphorylation as a robust marker of early ischemiaMuhammad Saddiq Zahari, Xinyan Wu, Sneha M Pinto, et al.
Oncotarget|December 1, 2016
The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancerXinyan Wu, Muhammad Saddiq Zahari, Santosh Renuse, et al.
Cancer Cell|September 13, 2017
Chronic Cigarette Smoke-Induced Epigenomic Changes Precede Sensitization of Bronchial Epithelial Cells to Single-Step Transformation by KRAS MutationsMichelle Vaz, Stephen Y Hwang, Ioannis Kagiampakis, et al.
Human Pathology|August 30, 2006
Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinomaTsui-Lien Mao, Chih-Yi Hsu, May J Yen, et al.
Breast Cancer Research : BCR|January 15, 2026
CRYβB2 is a biomarker for poor prognosis and response to CDK4/6 inhibitors in breast cancerYu Yan, Athira Narayan, Marzieh Mazinani, et al.
Pageof 14

Showing results (81-90 of 134) with videos related to

Sort By:
Pageof 14
Molecular Cancer Therapeutics|August 28, 2020
Concurrent Targeting of Potential Cancer Stem Cells Regulating Pathways Sensitizes Lung Adenocarcinoma to Standard ChemotherapyMasahiro Shibata, Akira Ooki, Yoshikuni Inokawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2004
Hypermethylation of the GATA genes in lung cancerMingzhou Guo, Yoshimitsu Akiyama, Michael G House, et al.
The Oncologist|March 1, 2018
A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy-Naïve Advanced or Metastatic Nonsquamous Non-Small Cell Lung CancerKristen A Marrone, Xian Zhou, Patrick M Forde, et al.
Plos Medicine|October 6, 2006
Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancerAnju Singh, Vikas Misra, Rajesh K Thimmulappa, et al.
Cancer Research|June 18, 2003
Dykellic acid inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting nuclear factor kappa B transcriptional activityJu-Hyung Woo, Jong-Wook Park, Sung-Hee Lee, et al.
Scientific Reports|September 3, 2015
Phosphoproteomic profiling of tumor tissues identifies HSP27 Ser82 phosphorylation as a robust marker of early ischemiaMuhammad Saddiq Zahari, Xinyan Wu, Sneha M Pinto, et al.
Oncotarget|December 1, 2016
The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancerXinyan Wu, Muhammad Saddiq Zahari, Santosh Renuse, et al.
Cancer Cell|September 13, 2017
Chronic Cigarette Smoke-Induced Epigenomic Changes Precede Sensitization of Bronchial Epithelial Cells to Single-Step Transformation by KRAS MutationsMichelle Vaz, Stephen Y Hwang, Ioannis Kagiampakis, et al.
Human Pathology|August 30, 2006
Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinomaTsui-Lien Mao, Chih-Yi Hsu, May J Yen, et al.
Breast Cancer Research : BCR|January 15, 2026
CRYβB2 is a biomarker for poor prognosis and response to CDK4/6 inhibitors in breast cancerYu Yan, Athira Narayan, Marzieh Mazinani, et al.
Pageof 14